EN DE

PT Surya Biru Murni Acetylene Tbk (SBMA) Fair Value & Analysis

Basic Materials · ID · Market cap 100B IDR

PS PT Surya Biru Murni Acetylene Tbk SBMA · JK
Price111.00 IDR
Fair Value132.68 IDR
Upside+19.5%
Quality55/100
Watch PT Surya Biru Murni Acetylene Tbk for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 7.4% net margin
Low debt · generates free cash flow
Ranks above peers (10/14)
Narrow moat 36/100
Evidence: High Range 86.45 IDR – 165.86 IDR Share as image

Fair value as of: Jul 18, 2026

From 26 valuation models · updated 24 days ago

Fair value updated Jul 18, 2026, revised from 215.57 IDR to 132.68 IDR (−38.5%) since Jun 24, 2026. Share price +2.8% over the past month.

A solid business, screening 20% undervalued on our models.

What matters now

  • A fairly wide model range (86.45 IDR to 165.86 IDR) leaves room in how you read the outcome.
  • Our model range runs from 86.45 IDR (bear) to 165.86 IDR (bull), base 132.68 IDR. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 55/100 (solid quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

480.39 IDR 92.12 IDR Fair Value 132.68 IDR Sep 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 18, 2026.

How to read this chart

59‑month range 92.12 IDR – 480.39 IDR · fair‑value band 86.45 IDR – 165.86 IDR · the 111.00 IDR price screens below the 132.68 IDR fair value. Dashed = 300-day average. As of Jul 18, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

PT Surya Biru Murni Acetylene Tbk (SBMA) currently trades at 111.00 IDR, while our model-based Fair Value estimate is 132.68 IDR, implying the stock looks roughly 19.5% undervalued today. The Quality Score stands at 55/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, PT Surya Biru Murni Acetylene Tbk generated revenue of 136B IDR at a net margin of 7.4%. Revenue declined 3.3% year over year. It earns a return on equity of 4.3%. Net debt stands at 19.4B IDR. Fundamentals as of Jul 18, 2026

Our scenario range runs from 86.45 IDR (bear case) to 165.86 IDR (bull case); at 111.00 IDR, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 28% below its 52-week high and 23% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -46% fair-value upside, at 20%, SBMA screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 109.32 IDR 189.80 IDR 322.92 IDR 80
Residual Income 196.79 IDR 198.76 IDR 189.55 IDR 76
Rev-Margin DCF 133.93 IDR 240.55 IDR 374.33 IDR 74
All 26 models by family
DCF Models
FCF DCF 109.44 IDR 195.05 IDR 339.23 IDR 38
Owner Earnings 110.36 IDR 196.65 IDR 341.98 IDR 31
5Y Revenue Exit 133.93 IDR 243.60 IDR 391.64 IDR 39
5Y EBITDA Exit 172.90 IDR 322.04 IDR 507.42 IDR 41
5Y P/E Exit 131.31 IDR 238.34 IDR 358.50 IDR 38
10Y Revenue Exit 119.35 IDR 220.10 IDR 371.98 IDR 36
10Y EBITDA Exit 150.09 IDR 276.80 IDR 466.68 IDR 37
10Y P/E Exit 122.79 IDR 216.29 IDR 344.88 IDR 35
Earnings-Based
Graham-Dodd 86.23 IDR 366.76 IDR 500.82 IDR 54
Lynch FV 93.56 IDR 133.66 IDR 173.75 IDR 50
PEG = 1.0 93.56 IDR 133.66 IDR 173.75 IDR 46
EPV 137.60 IDR 161.49 IDR 182.41 IDR 59
Dividend Discount
Gordon GGM 36.73 IDR 76.36 IDR 121.14 IDR 70
DDM Multi-Stage 36.73 IDR 64.39 IDR 80.15 IDR 61
Multiples
P/E Multiple 161.68 IDR 215.57 IDR 269.47 IDR 63
P/S Multiple 161.68 IDR 215.57 IDR 269.47 IDR 58
P/B Multiple 161.68 IDR 215.57 IDR 269.47 IDR 55
EV/EBIT 206.74 IDR 277.59 IDR 348.43 IDR 53
EV/EBITDA 223.55 IDR 300.00 IDR 376.45 IDR 54
EV/Revenue 149.08 IDR 215.45 IDR 281.83 IDR 43
Asset-Based
NCAV (Graham) 128.55 IDR 172.26 IDR 257.10 IDR 50
Growth DCF
Growth DCF 109.32 IDR 189.80 IDR 322.92 IDR 80
Rev-Margin DCF 133.93 IDR 240.55 IDR 374.33 IDR 74
Economic Profit
Residual Income 196.79 IDR 198.76 IDR 189.55 IDR 76
ROIC Compounder 137.60 IDR 161.49 IDR 182.41 IDR 72
Growth Earnings
Growth-Adj P/E 140.45 IDR 200.64 IDR 260.83 IDR 68

Widest divergence: DCF Models (220.10 IDR) versus Dividend Discount (64.39 IDR). Highest evidence: Growth DCF (80).

Notify me when SBMA reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 136B IDR
Revenue growth (YoY) -3.3%
Net margin 7.4%
Return on equity 4.3%
Free cash flow 8.6B IDR FY2025
P/E ratio 9.1
More key figures
Operating margin 3.6%
EPS (TTM) 11.82 IDR
EPS growth (YoY) -87.8%
Net debt 19.4B IDR FY2025

Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 55/100

Of which business quality 54 · Market factors (momentum, volatility) 43

Profitability 36
Margins and returns on capital today
Quality Growth 41
Are margins and returns improving?
Cashflow 48
Earnings quality: real cash, not paper profit
Fin. Strength 59
Balance sheet, leverage, solvency risk
Investment 75
Disciplined investing over empire-building
Low Volatility 80
Calm price path (market factor)
Momentum 26
Price trend over the last 3–12 months (market factor)
52W Momentum 29
Distance to the 52-week high (market factor)
Net Issuance 81
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

PT Surya Biru Murni Acetylene Tbk produces chemical industrial gases in Indonesia. It offers acetylene, oxygen, and nitrogen, as well as argon, carbon dioxide, helium, and mixed gases; and new air separation plant, cylinder maintenance, gas equipment and installation, transport and distribution, gas chromatograph, and gases for laboratory and testing …

Full company description

PT Surya Biru Murni Acetylene Tbk produces chemical industrial gases in Indonesia. It offers acetylene, oxygen, and nitrogen, as well as argon, carbon dioxide, helium, and mixed gases; and new air separation plant, cylinder maintenance, gas equipment and installation, transport and distribution, gas chromatograph, and gases for laboratory and testing applications. PT Surya Biru Murni Acetylene Tbk was founded in 1980 and is headquartered in Balikpapan, Indonesia. PT Surya Biru Murni Acetylene Tbk is a subsidiary of PT Surya Biru Titilea Investama.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

PT Surya Biru Murni Acetylene Tbk reported revenue of 137B IDR in FY2025 versus 88.3B IDR in FY2021, a compound +11.7%/yr. Reported net income was 11.8B IDR in FY2025, compounding +12.3%/yr from FY2021.

Growth Quality 83/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
137B IDR
Latest YoY
+4.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+9.8%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.1%
Avg. growth/yr (7Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.9%
Revenue +11.7%/yr
FY21 88.3B IDR
FY22 104B IDR
FY23 113B IDR
FY24 132B IDR
FY25 137B IDR
Net income +12.3%/yr
FY21 7.4B IDR
FY22 4.5B IDR
FY23 4.7B IDR
FY24 13.4B IDR
FY25 11.8B IDR

Watch SBMA: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "PT Surya Biru Murni Acetylene Tbk Fair Value". https://www.fairvalue-calculator.com/stock/SBMA

Peer Group

Chemicals · 338 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 55 · Above median
Fair Value upside +20% · Top 25%
Return on equity (TTM) 4% · Below median
Return on assets 4% · Above median
Net margin (TTM) 7% · Above median
Operating margin (TTM) 4% · Below median
Revenue growth -3% · Below median
Dividend yield (TTM) 0.0% · Bottom 25%
Debt / equity 0.05× · Lower than median

Valuation Multiples vs Chemicals median · lower = cheaper

P/E (TTM) 9.1× · Cheaper than 75% of peers
P/B 0.42× · Cheaper than 75% of peers
P/S (TTM) 0.74× · Cheaper than median
P/FCF 0.0× · Cheaper than 75% of peers
EV/EBITDA 4.0× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 59 · sector 0
FUTURE 0 · sector 23
PAST 17 · sector 19
HEALTH 98 · sector 94
DIVIDEND 0 · sector 27

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).

Stock Price Fair Value vs Fair Value
BASF SE BASN 1,034 MXN 532.13 MXN -49%
Ningxia Baofeng Energy Group 600989 ¥20.32 ¥20.17 -1%
Zhejiang Juhua Co 600160 ¥42.85 ¥23.35 -46%
PT Barito Pacific Tbk, BRPT 1,690 IDR 1,628 IDR -4%
LG Chem, Ltd 051910 260,500 KRW 587,755 KRW +126%
Formosa Chemicals & Fibre Corporation 1326 66.10 TWD 6.79 TWD -90%
PTT Global Chemical Public Company PTTGC 35.50 THB 18.21 THB -49%
542812 542812 ₹4,369 ₹791.05 -82%
Indorama Ventures Public Company IVL 24.50 THB 17.95 THB -27%
Navin Fluorine International Limited NAVINFLUOR ₹8,650 ₹2,146 -75%

Compare PT Surya Biru Murni Acetylene Tbk with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is PT Surya Biru Murni Acetylene Tbk (SBMA) overvalued or undervalued?
As of Jul 18, 2026, our model estimates a fair value of 132.68 IDR versus a price of 111.00 IDR, about +20% (undervalued).
What is the fair value of SBMA?
Our model-based fair value for PT Surya Biru Murni Acetylene Tbk is 132.68 IDR (as of Jul 18, 2026), built from audited fundamentals. The current price is 111.00 IDR.
What is the quality score of SBMA?
PT Surya Biru Murni Acetylene Tbk has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of PT Surya Biru Murni Acetylene Tbk (SBMA)?
PT Surya Biru Murni Acetylene Tbk reported trailing-twelve-month revenue of about 136B IDR (latest available figure, as of Jul 18, 2026).
What is the net profit margin of SBMA?
The net profit margin of PT Surya Biru Murni Acetylene Tbk is about 7.4%, meaning it keeps roughly 7.4% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track PT Surya Biru Murni Acetylene Tbk and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.